Vasomotor symptoms (Hot flashes/Night sweats) Market Insight, Epidemiology And Market Forecast Read More- https://www.delveinsight.com/infographics/vasomotor-symptoms-market?utm_source=marketing&utm_medium=promotion&utm_campaign=infographic

2. Vasomotor Symptoms (VMS) are episodes of profuse heat accompanied by sweating and
flushing, which are experienced majorly around the head, neck, chest, and upper back.
Vasomotor symptoms are often accompanied by hot flashes and night sweats and are often
considered as the cardinal symptoms of menopause. The VMS may also include heart palpitations
and changes in blood pressure.
Vasomotor Symptoms Epidemiology Segmentation in the 7MM
 Total Prevalent Cases of Vasomotor Symptoms
 Total Age-specific Cases of Vasomotor Symptoms
 Total Treated Cases of Vasomotor Symptoms
 Total Severity-specific Cases of Vasomotor Symptoms
Vasomotor Symptoms Epidemiological Insights Observed in the 7MM (2021)
 The total prevalent cases of Vasomotor Symptoms in 7MM were estimated to be 136.02
million.
 The Age-Specific prevalent cases of Vasomotor Symptoms in the 7MM were found to be 18.45
million in population aged between 40-44 years, 24.23 million in people with 45-49 years of
age, 26.15 million people of the age 50-54 years, 32.16 million of the population between 55-
59 years and 37.23 million people of the age 60-65 years.
Vasomotor Symptoms Market Insight
The market size of Vasomotor Symptoms in the 7MM was found to be approximately USD 15,026
million in the year 2021.
Vasomotor Symptoms Market Drivers
 Increasing awareness
 Rising emerging therapies
 Novel mechanism of action
 Increasing initiatives for R&D
Vasomotor Symptoms Market Barriers
 Generic nature of the market
 Limited understanding of the pathophysiology
 Lack of robust developmental pipeline
 Lack of trained and professional physicians

3. Vasomotor Symptoms Emerging Drugs
The emerging drugs in the Vasomotor Symptoms market are
 Donesta (E4, Estetrol)
 Elinzanetant (BAY-3427080, NT 814)
 Fezolinetant (ESN-364)
 MNGX-100 (Filgrastim, G-CSF)
 Elismetrep (MT-8554)
 Q-122 (MSX-122), and many others
Vasomotor Symptoms Key Players
The key players working in the Vasomotor Symptoms market are
 Estetra
 Mithra Pharmaceuticals
 Bayer
 Nerre Therapeutics Ltd.
 Astellas Pharma
 MenoGeniX
 Mitsubishi Tanabe Pharma
 QUE Oncology, and several others
Also, read- Vasomotor symptoms (Hot flashes/Night sweats) | Vasomotor symptoms (Hot
flashes/Night sweats) Infographics | Vasomotor symptoms (Hot flashes/Night sweats) Market